were maintained at 37°C under 5% CO 2 / 95% air. To culture for the subsequent extraction 10 of protein and total RNA, cells were seeded onto Petri plates at a density of 2 x 10 6 cells per 11 dish, and 3,5-di-O-CQA was added at a final concentration of 20 μM. 12 13
Determination of cell viability 14
To investigate the neuroprotective effect, we employed the Aβ-treated SH-SY5Y cell 15 model (Li et al., 1996; Wang et al., 2009 ). Cell viability was assessed using the 16 conventional MTT reduction assay. The cultured cells in 96-well plates (fibronectin coated 17 plate) were treated with 3,5-di-O-CQA and exposed to 2 μM Aβ 1-42 for 72 h, then 10 μl of 18 MTT stock solution (5 mg/ml) was added to the culture medium and incubated for 6 h at 19 37 °C. The formazan was extracted with 100 μl 10% SDS (W/V) and the absorbance was Samples containing 30 µg for analytical gels or 300 µg for preparative gels of protein were 3 separated by isoelectric focusing (IEF) and then by sodium dodecyl sulfate polyacrylamide 4 gel eletrophoresis (SDS-PAGE) using Ettan IPGphor II and Ettan DALTsix (GE Healthcare, 5
Uppsala, Sweden). For IEF, samples were added into the rehydration solution containing 8 6 M urea, 2% CHAPS, 0.5% IPG buffer, 0.002% bromophenol blue and 0.28% (w/v) 7 dithiothreitol (DTT), and then applied to a 24cm immobiline dry strips, which are dry 8 polyacrylamide gel strips with an immobilized pH gradient pH 3-10 (GE Healthcare). The 9 dry strips were rehydrated at 20 ℃ for 12 h and isoelectric focusing of proteins was carried 10 out at 500 V for 1 h, 1000 V for 1 h, 10000 V for 3 h, 10000 V for 2 h, and, 45 min. 11
Thereafter, IPG strips were reduced (1% DTT) and alkylated (2.5% iodoacetamide) in 12 equilibration buffer (6 M urea, 50 mM Tris-Cl, pH 8.8, 30% glycerol, 2% SDS). When the 13 equilibration was finished, the strips were loaded onto 12% acrylamide vertical gels and 14 separation of proteins with different molecular weight was carried out at 2.5 W per gel for 15 30 min, followed by 25 W per gel for 3.5 h. 16
Silver staining using Plus One Silver Staining Kit (GE Healthcare) was performed 17 according to the manufacturer's instructions. The stained gels were subjected to image 18 analysis by ImageMaster 2D Platinum software (ver. 4.9; GE Healthcare). Gels in which 19
proteins from either β-amyloid (Aβ) or caffeoylquinic acid (CA) treatment, or both, as well 20 as control were imported into the same platform and were subjected to image analysis. 21
After spot detection and matching, the spots of interest were manually selected and the 22 data regarding the relative intensities of these spots were obtained. Spots intensities were 1 expressed as percentages (% vol) of relative volumes by integrating the value (or OD) of 2 each pixel in the spot area (vol) and dividing it with the sum of the volumes of all the spots 3 detected in the gel. 4 5
In-gel digestion and mass spectrometry 6
For spot picking, preparative gels in which quantity of protein was ten times more than that 7 in analytical gels, were prepared. After coomassie brilliant blue (CBB) staining using 8
Coomassie Tablets, PhastGel R-350 (GE Healthcare), the protein spots of interest were 9 excised and put into 1.5 ml eppendorf tubes. After destaining, the spots were digested with 10 trypsin (sequencing grade, GE Healthcare) and the peptides were extracted. Prior to 11 analysis on mass spectrometer, the peptide solutions were desalted by Zip Tip C18 12 (Millpore, Tokyo, Japan). The peptide solutions were then applied onto MALDI plate 13 directly and the solution drop was allowed to air-dry. Furthermore, the matrix solution, 14 prepared by dissolving 10 mg of α-cyano-4-hydroxycinnamic acid (CHCA, Sigma, USA) 15 in 1 ml of 50% acetonitrile and 0.1% triflouroacetic acid in deionized water, was overlayed 16 onto the dried drops. After the matrix solution was dried, the plate was inserted into the 17 MALDI-TOF mass spectrometer and was subjected to peptide mass fingerprinting. All the 18 MALDI-TOF mass spectra were acquired on AXIMA-CFR mass spectrometer. 
Real-time PCR 5
To find the trigger genes on the neuroprotective effect of 3,5-di-O-CQA, we considered the 6 lower concentration (10 μM ) and shorter treatment time (16 h). After incubating seeded 7 plates for 16 h, total RNA was purified using the ISOGEN kit (Nippon Gene Co. Ltd., 8 Japan). Total RNA was quantified by measurement of the spectrophotometer at 260 nm 9 with a UV spectrophotometer and was also measured at 280 nm to assess purity. Only RNA 10 with a 260/280 ratio higher than 1.8 was used for real-time PCR. The template cDNA was 11 synthesized from total RNA using the SuperScript reverse transcriptase system (Invitrogen). 12
Briefly, RNA was denatured at 65 ℃ for 5 min and incubated with 1 µL oligo (dT) 12-15 13 primers and chilled at 4℃. After adding SuperScript II reverse transcriptase (200 units) the 14 reaction mix was incubated at 42 ℃ for 60 min, then 10 min at 70 ℃ (16). For the 15 quantification of mRNA, nested primers were designed using Primer3 input software 16 (http://frodo.wi.mit.edu/cgi-bin/primer3/ primer3.cgi/primer3_www.cgi). Quantitative PCR 17 reactions were performed in a MiniOpticon instrument (Bio-Rad, USA) and carried out as 18 recommended for iQ SYBRGreen supermix (Bio-Rad). Briefly, the RT mix (2 µL) was 19 used as template for the real-time PCR mix containing 0.5 mM forward (5' 20 ACAATGGAGCCAAGTCGGTAG-3') and reverse (5'-21 GCCTACACAGTCCTTCAAGAAC-3') nested primers (2 µL each) and 2 x SYBR Green 22 supermix (10 μL). The amplification conditions were: 3 min at 95℃, 10 s at 95℃, 30 s at 1 62℃, and 30 s at 72℃ for 34 cycles. At the end of the reaction, a melting curve analysis 2 was carried out to check for the presence of primer-dimers. After the open field test, the MWM was selected as a method for the evaluation of the 5 spatial learning and memory. A circular water tank (120 cm in diameter and 50 cm in 6 height) was filled with water to a depth of 30 cm. Inside the tank, an escape platform (11 7 cm in diameter) was placed, with the top of 1 cm below the water surface. The platform 8 was in the middle of the target quadrant, and its position remained fixed during the 9 experiment. Above the tank, a white floor-to-ceiling cloth curtain was drawn around the 10 pool, and four kinds of black cardboard (circle, triangular, rhombus and square) were hung 11 equidistantly on the interior of the curtain serving as spatial cues. Each mouse had daily 12 sessions of one trial for 30 consecutive days. When they succeeded, mice were allowed to 13 stay on the platform for 30 s. When the mice failed to find the platform within 60 s, they 14
were assisted by the experimenter and allowed to stay the platform for the same time. A 15 probe trial was performed 24 h after the last training session. In this trial, the platform was 16 removed from the tank and mice were allowed to swim freely for 60 s. 17
18
Statistical analysis 19
The escape latency of mice in the MWM training was analyzed using the two-way analysis 20 of variance (ANOVA) with repeated measures, the factors being treatment and training day. To investigate the upregulated glycolytic enzyme's effects on energy generation, the levels 7 of ATP, which is the end product of glycolysis, were evaluated. ATP is a multifunctional 8 nucleotide that is important as a "molecular currency" of intracellular energy transfer. In 9 this role, ATP transports chemical energy within cells for metabolism. Intracellular ATP 10 production level of 3,5-di-O-CQA-treated SH-SY5Y cells was measured by a luciferase 11 reaction method. In 3,5-di-O-CQA-treated SH-SY5Y cells, luminescence was significantly 12 upregulated by 113% ±7.2 compared to non-treated group (P<0.05) (Fig. 4) . 13 14
Effect of CQA on spatial learning and memory of SAMP8 mice in MWM 15
We measured the time, swimming time to arrive at the platform (escape latency time), to 16 assess the effect of 3,5-di-O-CQA on spatial learning and memory, which is AD's major 17 symptom. We noted that the 3 month-old SAMP8 and SAMR1 mice demonstrated 18 significant differences in motivational swimming speed between groups (data not shown). 19
As shown in Fig. 5 , all groups (SAMP8, SAMP8+CQA, SAMR1 group) improved their 20 performance after 30 days. However, the escape latency time of SAMP8 group (n=10) was 21 slightly decreased, compared with SAMR1 and SAMP8+CQA groups. The escape latency 22 time of SAMP8+CQA and SAMR1 group (n=10) was significantly decreased compared to 1 SAMP8 group (P<0.01). There was no significant difference between SAMP8+CQA and 2 SAMR1group on the escape latency time. 3 4
Effect of CQA on the mRNA expression level of PGK1 on SAMP8 mice brain 5
We investigated the mRNA expression level of PGK1 on SAMP8 mice brain to determine 6 the effect of 3,5-O-di CQA on PGK1 expression in vivo. From the real-time PCR result 7 ( Fig. 6) , the mRNA expression level of PGK1 was highly increased in the brain of 3,5-di-8 O-CQA administrated SAMP8 mice. In fact, the PGK1 mRNA expression in 9
SAMP8+CQA group was significantly upregulated by 153% ±7.5 compared with the 10 SAMR1 group (P<0.01). However, the PGK1 mRNA expression in SAMP8 group was 11 slightly down-regulated compared to SAMR1 group (not significantly). substrate of acetylcholine synthesis is acetylcoenzyme A, which is exclusively synthesized 21 in the glycolytic pathway in the brain. Glucose matabolism, final products of which are 22 1 and the amyloid protein accumulation in the brain may be a secondary phenomena caused 2 by the decline in glucose metabolism in senile dementia (Benson et al., 1983; Tucek et al., 3 1990 ). 4
In the presence of oxygen, glucose undergoes complete combustion to create CO 2 5 and H 2 O. The energy produce reaction that liberates free energy, which is trapped as ATP 6 into two consecutive processes: glycolysis and oxidative phosphorylation in mitochondria. 7
The impairment of glycolytic metabolism of glucose in the endothelium of BBB, and the 8 dysfunction of glycolysis pathway cause hypoglycemia in the brain which may initiate the 9 accumulation of amyloid protein in the brain (Hagino et al., 2004) . report that CQA induced the activation of ATP production in neuronal cells. Our study is 20 the first report on the new function of CQA as a stimulator of ATP production. Exposure of 21 neuronal cells to the strict circumstance, such as cell toxic and chronic hypoxia stimulates 22 the expression of glucose transporters and enzymes that accelerate glucose utilization to 1 compensate for the reduced production of ATP (Gao et al., 2004) . Such a response is 2 gradually late and weak in aging cells. From our results, we suggest that CQA contribute to 3 the homeostasis of ATP production in cells, especially on neuronal cells. Particularly, PGK1 is an important glycolytic enzyme because this enzyme that 21 induces the production of 2 molecules of ATP in glycolysis pathway. Furthermore, PGK1 22 is not a rate limiting enzyme which is Hexokinase, Phosphofructokinase, Pyruvate kinase, 1 in the glycolysis pathway (Theresa et al., 1982) . Therefore, the activation of PGK1 enzyme 2 is not affected by the feedback inhibition on ATP production. We suggest that 3,5-di-O-3 CQA can induced the activation of ATP production without feedback inhibition through the 4 activation of PGK1. 5 6 CONCLUSION 7
In conclusion, we found that 3,5-di CQA has a neuroprotective effect on Aβ 1-42 8 treated SH-SY5Y cells. The mRNA expression of glycolytic enzyme (PGK1) and the 9 intracellular ATP level were increased in 3,5-di-O-CQA-treated SH-SY5Y cells. We also 10 found that 3,5-di-O-CQA administration induced the improvement of spatial learning and 11 memory on SAMP8 mice, and the overexpression of PGK1 mRNA level. These findings 12 suggest that 3,5-di-O-CQA has a neuroprotective effect through the induction of PGK1 13 expression and ATP production activation. software. These spots were identified as PGK1 by MALDI-TOF mass spectrometry. 9
Each bar represents the mean ± SD (n = 3). **P<0.01 (vs control). 
